Dianthus Therapeutics, Inc.

Historical 13F Holders

Symbol
DNTH
CUSIP
252828108
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 170 47.2 M $1.95 B
2025 Q3 149 46.9 M $1.85 B
2025 Q2 108 39.1 M $729 M
2025 Q1 105 37.7 M $685 M
2024 Q4 99 35.1 M $766 M
2024 Q3 95 31.4 M $859 M
2024 Q2 78 29.7 M $770 M
2024 Q1 80 26.1 M $784 M
2023 Q4 43 10.6 M $110 M
2023 Q3 32 10.1 M $136 M